Cansu Yerinde
@cyerinde
Postdoctoral fellow @MGH and @HarvardMed Cancer and Immunology, PhD @ChariteBerlin, formerly @Unibogazici
ID: 1308346937616236544
22-09-2020 10:06:43
51 Tweet
102 Takipçi
305 Takip Edilen
Excited to share our most recent publication Cell Stem Cell. Unexpectedly, we found that hematopoietic stem cells act as antigen presenting cells! Antigen presentation safeguards the integrity of the stem cell pool and prevents the onset of leukemias (1/8).authors.elsevier.com/c/1f1286tu0CiG…
I’m very excited to share my first, first author research paper with Sherry Zhang! Vignali Lab Nature Immunology nature.com/articles/s4159…
Delighted to share our story out in Cancer Cell! Incredible amount of work led by Julia Belk and Winnie Yao, and wonderful collaborations with many close colleagues Santosh Vardhana Julia Carnevale Marson Lab Mackall Lab cell.com/cancer-cell/fu…
BRCA1/2-mutierte #Krebszellen überleben Chemo- und Strahlentherapie oft. Ein Team um #mdcBerlin-Forscher Claus Scheidereit schafft nun die Grundlage, damit gezieltere #Medikamente entwickelt werden können. #Brustkrebs The EMBO Journal Ahmet Bugra Tufan mdc-berlin.de/de/news/press/…
My PhD paper is finally out The EMBO Journal. Special thanks to our brilliant collaborators at FMP Berlin and Max Delbrück Center respectively. embopress.org/doi/full/10.15… Also special thanks to the journalists who made a press release about our study. mdc-berlin.de/news/press/kee…
BRCA1/2-mutated #CancerCells often survive chemo- and radiotherapy. A team led by #mdcBerlin researcher Claus Scheidereit has now paved the way for the development of more targeted drugs. FMP Berlin The EMBO Journal EMBO Ahmet Bugra Tufan #BreastCancer More: mdc-berlin.de/news/press/kee…
An unlikely new activator of #DNAdamage-induced #NFkB signaling and #PARP1 #PARylation: Claus Scheidereit Ahmet Bugra Tufan et al Max Delbrück Center reveal new #ESCRT-independent function of #TSG101 embopress.org/doi/10.15252/e…
Finally, the paper that covers most of my work from my PhD has been published in Molecular Oncology . In this paper, we are investigating the role of interferon regulatory factor 4 (IRF4) in melanoma cells. (1/) febs.onlinelibrary.wiley.com/doi/10.1002/18…
Interferon regulatory factor 4 modulates epigenetic silencing and cancer-critical pathways in melanoma cells ➡️buff.ly/4b5BCV7 🥼Ulduz Sobhiafshar Tolga Emre Cansu Yerinde Elif Nur Firat-Karalar #IRF4 #Melanocytes #Epigenetics